Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Pulmonary Emphysema
and you are
over 40
years old
The phase for this study is not defined.
Show me locations

The purpose

The study hypothesis is that patients with homogeneous emphysema behave differently compared to heterogeneous emphysema with respect to exercise capacity. A better understanding of this difference will allow the investigators to choose the best treatment for each type of patient. The main purpose of this study is to evaluate the change in exercise capacity measured by cycle ergometry in patients with severe emphysema after endoscopic lung volume reduction with coils (eLVR). As a secondary purpose, the investigators want to perform an exploratory, randomized study to compare the results of two different therapeutic approaches in a small sample of patients with homogeneous emphysema.

Provided treatments

  • Procedure: 10 coils in upper lobes
  • Procedure: 15 coils in upper and lower lobes
  • Procedure: cycloergometry
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02879331. The sponsor of the trial is Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz and it is looking for 35 volunteers for the current phase.
Official trial title:
Clinical Study to Evaluate the Exercise Capacity in Patients With Severe Emphysema Treated With Coils